Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease
{{output}}
Rationale: Sickle cell disease (SCD) is a monogenetic condition with recurring vasoocclusive events causing lifelong pulmonary morbidity and mortality. There is increasing access to curative therapies, such as hematopoietic cell transplant (HCT), for people li... ...
